Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
3.600
+0.150 (4.35%)
At close: Jun 10, 2025, 4:00 PM
3.780
+0.180 (5.00%)
After-hours: Jun 10, 2025, 5:57 PM EDT
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $155.59 million as of June 10, 2025. Its market cap has decreased by -72.93% in one year.
Market Cap
155.59M
Enterprise Value
-77.96M
1-Year Change
-72.93%
Ranking
Category
Stock Price
$3.60
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $155.59M, a decrease of -82.68%. That is a compound annual growth rate of -73.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2025 | 149.11M | -7.65% |
| Dec 31, 2024 | 161.46M | -82.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.15B |
| Johnson & Johnson | 373.01B |
| AbbVie | 335.32B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.06B |
| Abbott Laboratories | 232.41B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.14B |